Identifying patients with prostate cancer at increased risk for haematuria during anticoagulation for venous thromboembolism-Reference-Cited by-同舟云学术

Identifying patients with prostate cancer at increased risk for haematuria during anticoagulation for venous thromboembolism

Published:2023-12 Issue: Volume:232 Page:54-61
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Paredes Diana,del Carmen Díaz-Pedroche María,Gómez-Cuervo Covadonga,Pérez-Jacoiste Asunción,Valle Reina,Blanco-Molina Ángeles,López-Sáez Juan Bosco,Meireles Jose,Sarlon-Bartoli Gabrielle,Monreal Manuel

Publisher

Elsevier BV

Subject

Hematology

Reference23 articles.

1. Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism;Farge;Medicine (Baltimore) [Internet],2015

2. The clinical course of venous thromboembolism may differ according to cancer site;Mahé;Am. J. Med. [Internet],2017

3. Incidence and Morbidity of Radiation-Induced Hemorrhagic Cystitis in Prostate cancer. Urology [Internet];Martin,2019

4. Performance of five different bleeding-prediction scores in patients with acute pulmonary embolism;Klok;J. Thromb. Thrombolysis [Internet].,2016

5. The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism;Palareti;J. Thromb. Haemost. [Internet].,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting intracranial bleeding during anticoagulation for venous thromboembolism within different time frames: Findings from the RIETE registry;Thrombosis Research;2024-09

2. Pharmacogenetic and clinical risk factors for bevacizumab-related gastrointestinal hemorrhage in prostate cancer patients treated on CALGB 90401 (Alliance);The Pharmacogenomics Journal;2024-03-04